![Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283806013613-gr2.jpg)
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/cb3c06b7-d646-416d-bfe7-c647f52d8387/bju15724-fig-0001-m.jpg)
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
![Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy](https://www.mdpi.com/diagnostics/diagnostics-11-00622/article_deploy/html/images/diagnostics-11-00622-g001.png)
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
![Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management | Journal of Nuclear Medicine Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/59/1/89/F2.large.jpg)
Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management | Journal of Nuclear Medicine
![Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/36f368ac-c7b1-4b20-9b5d-f7b2866b3819/bju15724-fig-0002-m.jpg)
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
![Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283806013613-gr3.jpg)
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://cdnintech.com/media/chapter/41807/1512345123/media/image1.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2490-14-49/MediaObjects/12894_2013_Article_339_Fig2_HTML.jpg)
Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text
CUAJ – Review Danielson et al Management of non-metastatic prostate cancer Management algorithms for prostate-specific antigen
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image6.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology](https://www.auajournals.org/cms/asset/57cd23a1-cfd8-4e19-80b1-1d21ce7d2fb6/juro.2020.203.issue-6.cover.jpg)
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology
![Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283806013613-gr1.jpg)
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients | Scientific Reports Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-29634-5/MediaObjects/41598_2023_29634_Fig1_HTML.png)
Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients | Scientific Reports
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image2.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-20319-z/MediaObjects/41598_2022_20319_Fig1_HTML.png)
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports
![IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/8/e002903/F5.large.jpg)
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image11.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
![Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients](https://www.mdpi.com/tomography/tomography-08-00226/article_deploy/html/images/tomography-08-00226-g001.png)